Message Font: Serif | Sans-Serif
No. of Recommendations: 1

Gilead's Acquisitive Mood
By Brian Lawler
July 21, 2006

With the Nasdaq biotech index down 13% for 2006, most biotech investors are having a bad year. Not so for investors in Gilead Sciences (Nasdaq: GILD); shares of the biopharmaceutical company have risen more than 9% since the year began.

Yesterday, Gilead released results from its busy and acquisitive second quarter. Just last month, the company purchased a manufacturing facility for $144 million. Two days ago, Gilead announced its purchase of the remaining shares of privately held Corus Pharmaceuticals for $365 million.....
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.